Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Bridging the Gap: New Bipartisan Legislative Push Targets Substance Use Recovery and Treatment Infrastructure on October 24, 2026 Posted by
The Future of Healing: CRI’s 2026 Gala Spotlights the "Next is Now" Era of Immunotherapy on October 24, 2026 Posted by
The Invisible Obstacle: How Fluid Viscosity Fuels Glioblastoma Aggression on October 24, 2026 Posted by
Investigational CAR T-Cell Therapy Zola-Cel Under Scrutiny Following Fatal Event in MS Trial on October 24, 2026 Posted by
The Silent Surge: Why Strokes Are Targeting Younger Adults at Alarming Rates on October 24, 2026 Posted by
Bridging the Gap: ERS Joins Global Coalition to Champion Scientific Integrity and Public Health on October 24, 2026 Posted by
The Evolution of Hope: Understanding the Significance of National Recovery Month on October 24, 2026 Posted by
Posted in Sleep Health Debunking the Myths: A Neuroscientist Clarifies the Reality of Narcolepsy and Cataplexy on August 3, 2026
Posted in Sleep Health FDA Grants Fast Track Designation to Lundbeck’s Lu AH69593: A Potential Paradigm Shift in Narcolepsy Treatment on August 3, 2026
Posted in Sleep Health New Horizons in Narcolepsy Treatment: Alkermes Reports Sustained Efficacy for Alixorexton in Long-Term Study on August 2, 2026
Posted in Sleep Health The Biology of Joy: Unlocking the Neural Mystery Behind Narcolepsy-Linked Cataplexy on July 31, 2026
Posted in Sleep Health Redefining Vigilance: Why ‘Microsleeps’ Are Changing the Standard for Narcolepsy Treatment on July 27, 2026
Posted in Sleep Health Beyond Wakefulness: How New Orexin Research is Redefining Narcolepsy Type 1 Treatment on July 27, 2026
Posted in Sleep Health Breakthrough in Narcolepsy Treatment: Alkermes’ Alixorexton Shows Sustained Efficacy in Long-Term Clinical Study on July 25, 2026
Posted in Sleep Health Breakthrough in Sleep Medicine: FDA Grants Fast Track Designation to Lundbeck’s Lu AH69593 for Narcolepsy Treatment on July 23, 2026
Posted in Sleep Health The Equity Gap: Why Progress in Narcolepsy Treatment Is Leaving Vulnerable Populations Behind on July 22, 2026
Posted in Sleep Health Beyond the Stereotype: A Neuroscientist’s Deep Dive into the Reality of Narcolepsy and Cataplexy on July 20, 2026
